Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

145.51 +3.25 (+2.28%)

Streaming Delayed Price Updated: 10:29 AM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

7 Analysts Have This to Say About Masimo ↗

May 04, 2022

Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter:

Via Benzinga

Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues ↗

May 04, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 03, 2022

Gainers

Via Benzinga

Masimo Reports First Quarter 2022 Financial Results

May 03, 2022

From Masimo

Via Business Wire

Masimo's Earnings Outlook ↗

May 02, 2022

Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an...

Via Benzinga

Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1™ Watch for Consumers

May 02, 2022

From Masimo

Via Business Wire

Supply Chain Challenges To Hit Masimo's Q1 FY22 Sales ↗

March 31, 2022

Via Benzinga

Masimo SedLine® Brain Function Monitoring Reduced the Use of Anesthetic Agents and Opioids in a Study on Patients Undergoing Cardiac Surgery

April 25, 2022

From Masimo

Via Business Wire

New JAMA Article Highlights the Outcome and Safety Benefits of Remote Patient Monitoring During the Pandemic and Beyond

April 18, 2022

From Masimo

Via Business Wire

Why Jim Cramer Recommends Buying Norwegian Cruise Line ↗

March 03, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Norwegian Cruise Line Holdings Ltd. (NYSE...

Via Benzinga

Is Masimo 'Crazy Like A Fox' For Spending $1.03 Billion To Buy Sound United? ↗

February 16, 2022

Investors were left scratching their heads after Masimo announced the buyout.

Via Investor's Business Daily

Masimo Closes Acquisition of Sound United

April 12, 2022

From Masimo

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 ↗

April 06, 2022

Upgrades

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

March 31, 2022

Goldman Sachs raised the price target on Consolidated Edison, Inc. (NYSE: ED) from $65 to $83. Consolidated Edison shares rose 0.5% to trade at $95.24 on Thursday.

Via Benzinga

The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall ↗

March 31, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Masimo Announces Certain Preliminary First Quarter 2022 Financial Results and Reaffirms Full-Year 2022 Revenue Guidance

March 30, 2022

From Masimo Corporation

Via Business Wire

New Study Finds That Noninvasive and Continuous Hemoglobin Improved Transfusion Management and Outcomes in Pediatric Patients

March 28, 2022

From Masimo

Via Business Wire

Analyst Ratings For Masimo ↗

March 17, 2022

Analysts have provided the following ratings for Masimo (NASDAQ:MASI) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings...

Via Benzinga

Masimo Debuts Telehealth for Patient SafetyNet™ at HIMSS 2022 Global Health Conference

March 14, 2022

From Masimo

Via Business Wire

Masimo's SedLine Brain Function Monitor Sensor Scores FDA Approval For Pediatric Use ↗

February 28, 2022

The FDA has FDA cleared Masimo Corp's (NASDAQ: MASI) SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG...

Via Benzinga

Masimo Announces FDA Clearance of Pediatric Indication for SedLine® Brain Function Monitoring and the SedLine Pediatric EEG Sensor

February 28, 2022

From Masimo

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022 ↗

February 18, 2022

Upgrades Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 17, 2022

Gainers Rhythm Pharmaceuticals (NASDAQ:RYTM) stock increased by 16.4% to $7.72 during Thursday's regular session. The current volume of 639.5K shares is 152.7% of...

Via Benzinga

Masimo Whale Trades Spotted ↗

February 16, 2022

Someone with a lot of money to spend has taken a bullish stance on Masimo (NASDAQ:MASI). And retail traders should know. We noticed this today when the big position showed up on publicly available...

Via Benzinga

56 Biggest Movers From Yesterday ↗

February 17, 2022

Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead...

Via Benzinga

Mid-Afternoon Market Update: US Stocks Pare Losses; S&P 500 Turns Higher ↗

February 16, 2022

US stocks pared losses toward the end of trading on Wednesday following the release of Fed minutes.

Via Benzinga

MASI Stock: The Masimo-Sound United Deal That Has Investors Scratching Their Heads ↗

February 16, 2022

Masimo (MASI) stock is falling hard on Wednesday after the company revealed plans to acquire Sound United for a whopping $1.025 billion.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Wednesday ↗

February 16, 2022

On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 2%; EIA Reports Unexpected Rise In Crude Inventories ↗

February 16, 2022

US stocks traded lower midway through trading on Wednesday ahead of the release of Fed minutes.

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

February 16, 2022

Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral...

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.